C07H 15/232
With at least three saccharide radicals in the molecule
Official title: with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin
C07H15/232 (With at least three saccharide radicals in the molecule) appears on 48 US grants and 45 published applications in this corpus.
Search patents in C07H- Granted patents
- 48
- Published applications
- 45
- Assignees
- 41
- Inventors
- 145
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 4 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 1 | 4 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 6 |
| 2012 | 2 | 6 |
| 2013 | 6 | 2 |
| 2014 | 3 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 1 | 0 |
| 2018 | 0 | 3 |
| 2019 | 0 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 3 |
| 2022 | 3 | 2 |
| 2023 | 4 | 1 |
| 2024 | 1 | 0 |
| 2025 | 2 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Neomycin based compounds, and pharmaceutical use thereof30 Dec 2025US 12,508,275 B2Centre Hospitalier Universitaire De Nice
- Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome22 Jul 2025US 12,364,706 B2Technion Research & Development Foundation Limited
- Modular synthesis of aminoglycosides29 Oct 2024US 12,129,274 B2Revagenix, Inc.
- Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function12 Dec 2023US 11,839,658 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Chromatographic material having improved pH stability, method for preparation thereof and uses thereof14 Nov 2023US 11,813,588 B2Dionex Corporation
- Broad spectrum aminoglycosides and uses thereof30 Jan 2025US 2025/0032524 A1Revagenix, Inc.
- Modular synthesis of aminoglycosides1 Jun 2023US 2023/0167148 A1Revagenix, Inc.
- Modular synthesis of aminoglycosides29 Dec 2022US 2022/0411456 A1Revagenix, Inc.
- Neomycin based compounds, and pharmaceutical use thereof15 Dec 2022US 2022/0395523 A1Centre Hospitalier Universitaire De Nice
- Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome9 Sep 2021US 2021/0275557 A1Technion Research & Development Foundation Limited
Most cited
By later US patents
- Salts of tetracyclines80US 5,538,954 AA/S Dumex (Dumex Ltd.) · 1996
- Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents40US 7,893,039 B2Isis Pharmaceuticals, Inc. · 2011
- Drug salts28US 6,077,822 ADumex-Alpharma A/S · 2000
- Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents20US 8,114,856 B2Isis Pharmaceuticals, Inc. · 2012
- Paromomycin or its derivatives or salts thereof in combination with sodium stirogluconate for parenteral treatment of human parasitic diseases17US 5,470,836 AFarmitalia Carlo Erba S.p.A. · 1995